Loading organizations...
Key people at Qianrong Holdings.
Qianrong Holdings was founded in 2008 by Xia Yujie (Founder).
Jiangsu Qianrong Capital Management operates as a venture capital firm focused on early-stage investments. It allocates capital to Series A funding rounds for promising startups across high technology, life sciences, and consumer sectors, primarily in China. The firm's model identifies and nurtures innovative companies through their foundational development and expansion.
Established in 2011 in Suzhou, China, the firm was founded on the insight that strategic capital is crucial for the nation's burgeoning innovation ecosystem. This understanding propels its mission to provide essential early-stage funding and guidance, empowering emerging enterprises in dynamic technology and scientific research to achieve growth.
The firm serves nascent companies requiring financial backing for Seed, Series A, and select Series B rounds. Jiangsu Qianrong Capital Management aims to cultivate a robust ecosystem of forward-thinking enterprises. Its vision is to accelerate the development and market integration of ventures, driving advancements across its target industries.
Qianrong Holdings was founded in 2008 by Xia Yujie (Founder).
Key people at Qianrong Holdings.
Qianrong Holdings has 1 tracked investment across 1 company. The latest tracked deal is $45.0M Series A in Thousand Oaks Biopharmaceuticals in January 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 3, 2019 | Thousand Oaks Biopharmaceuticals | $45.0M Series A | Liefeng Qu | Blue Bay Capital, Ji Lin Ao Dong, Tenyall & Sumin |
